Case Report: Hepatic Sarcoid-Like Reaction Associated With Checkpoint Inhibition in a NSCLC Patient and a Literature Review

Immune checkpoint inhibitor (ICI) treatment has dramatically revolutionized the landscape of therapeutic approaches in multiple cancers, particularly, non-small-cell lung cancer (NSCLC). With the increasing use of programmed death-1 (PD-1) inhibitors in the clinic, the emerging toxicity profile pres...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yuxin, Zhu, Wei, Wu, Bingchen, Lan, Huiyin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960956/
https://www.ncbi.nlm.nih.gov/pubmed/35359368
http://dx.doi.org/10.3389/fonc.2022.824308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960956/
https://www.ncbi.nlm.nih.gov/pubmed/35359368
http://dx.doi.org/10.3389/fonc.2022.824308

Ejemplares similares